<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00928616</url>
  </required_header>
  <id_info>
    <org_study_id>108/07</org_study_id>
    <secondary_id>108/07</secondary_id>
    <nct_id>NCT00928616</nct_id>
  </id_info>
  <brief_title>Differential Effects of a Diet Supplementation With Plant Sterol Esters on Human Monocytes</brief_title>
  <acronym>PSE-MO</acronym>
  <official_title>Differential Effects of &quot;Functional Foods&quot; Supplemented With Plant Sterol Esters on Blood Cells and Serum Parameters.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Saarland</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Saarland</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the effects of a diet supplementation with plant
      sterol esters on serum lipids, plant sterol concentrations and monocyte subpopulations.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study investigates effects of a diet supplementation with plant sterol esters on serum
      lipids, plant sterol concentrations and monocyte subpopulations.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>April 2009</start_date>
  <completion_date type="Anticipated">June 2009</completion_date>
  <primary_completion_date type="Anticipated">June 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>monocyte subpopulations</measure>
    <time_frame>4 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>serum parameters (lipids, plant sterol concentrations, inflammation parameters)</measure>
    <time_frame>4 weeks</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">16</enrollment>
  <condition>Hyperlipidemia</condition>
  <arm_group>
    <arm_group_label>plant sterol esters</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Participants consume plant sterol ester supplemented margarine (3 g/day)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo is a non-sterol ester supplemented margarine</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>margarine + plant sterol esters</intervention_name>
    <description>margarine supplemented with plant sterol esters (3g/day) over the time period of 4 weeks</description>
    <arm_group_label>plant sterol esters</arm_group_label>
    <other_name>plant sterols</other_name>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>margarine (placebo)</intervention_name>
    <description>non-sterol ester supplemented margarine</description>
    <arm_group_label>Placebo</arm_group_label>
    <other_name>regular margarine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy individuals without known cardiovascular diseases

        Exclusion Criteria:

          -  drugs that interfere with cholesterol metabolism

          -  other use of dietary supplements

          -  vegetarianism
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Oliver Weingärtner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universitätsklinikum des Saarlandes, Klinik für Innere Medizin III</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Universitätsklinikum des Saarlandes, Klinik für Innere Medizin III</name>
      <address>
        <city>Homburg</city>
        <state>Saarland</state>
        <zip>66421</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>June 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>June 25, 2009</study_first_submitted>
  <study_first_submitted_qc>June 25, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 26, 2009</study_first_posted>
  <last_update_submitted>June 25, 2009</last_update_submitted>
  <last_update_submitted_qc>June 25, 2009</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 26, 2009</last_update_posted>
  <responsible_party>
    <name_title>Oliver Weingärtner MD</name_title>
    <organization>University of the Saarland</organization>
  </responsible_party>
  <keyword>hyperlipidemia</keyword>
  <keyword>plant sterols</keyword>
  <keyword>monocytes</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyperlipidemias</mesh_term>
    <mesh_term>Hyperlipoproteinemias</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

